I-Mab partners with CSPC for long-acting GLP-1 Fc Program

Pharma |  News | 0 Comment | 17 Dec, 2018

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company focused on the development of innovative biologics in immuno-oncology and autoimmune diseases and CSPC P...Read more

Eisai signs pact with Eurofarma for anti-Obesity agent

Pharma |  News | 0 Comment | 17 Dec, 2018

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the Unit...Read more

Prestige, Cipla unite to sell cancer biosimilar HD201

Pharma |  News | 0 Comment | 14 Dec, 2018

Prestige BioPharma (“Prestige”) has reached a licensing agreement with Cipla Limited (“Cipla”) for its trastuzumab biosimilar (HD201) under which Cipla will hav...Read more

Luye Pharma submits its Parkinson’s drug for clinical trial approval

Pharma |  News | 0 Comment | 13 Dec, 2018

Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003) for the treatment of Parkinson's disease has been submitted to the ...Read more

Eisai, Takeda and GARDP sign pact to develop novel antibiotics

Pharma |  News | 0 Comment | 13 Dec, 2018

The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen compone...Read more

Mayne Pharma receives FDA approval of Tolsura

Pharma |  News | 0 Comment | 12 Dec, 2018

Australia-based Mayne Pharma announced that the US FDA has approved the New Drug Application (NDA) for Tolsura 65mg capsules. Tolsura is a new formulation of itraconazole indicated for...Read more

Menarini to sell Meropenem/vaborbactam in Europe, Asia-Pacific and CIS

Pharma |  News | 0 Comment | 12 Dec, 2018

The Menarini Group has recently reached an agreement with Melinta Therapeutics to commercialize meropenem/vaborbactam in Europe, Asia-Pacific and Commonwealth of Independent ...Read more

Strides Vivimed JV receives approval for Albendazole Tablets

Pharma |  News | 0 Comment | 12 Dec, 2018

Strides  Pharma Science  Limited  (Strides)  has announced that its 50:50 JV Strides Vivimed Pte. Ltd, Singapore has received approval for Albendazole Tablets USP 200 mg...Read more

HitGen, Mitsubishi Tanabe Pharma ink deal to foster drug discovery

Pharma |  News | 0 Comment | 11 Dec, 2018

China-based HitGen announced that the company has entered into a drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation to identify novel small molecule leads for t...Read more

Mundipharma to distribute Norspan in Japan

Pharma |  News | 0 Comment | 11 Dec, 2018

Mundipharma and Hisamitsu Pharmaceutical have agreed that Hisamitsu Pharmaceutical will end distribution of dermally absorbed buprenorphine adhesive agent Norspan Tape (buprenorphine) ...Read more

WuXi AppTec expands California Site for Pharma R&D

Pharma |  News | 0 Comment | 10 Dec, 2018

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, has announced the expansion of its facilities ...Read more

Daiichi Sankyo shows updated Phase 1 Data for U3-1402 in cancer patient

Pharma |  News | 0 Comment | 06 Dec, 2018

Daiichi Sankyo Company, Limited announced that updated efficacy and safety results from the ongoing phase 1/2 study of U3-1402, an investigational and potential first-in-class HER...Read more

AUM Biosciences acquires anti-cancer drug from A*STAR

Pharma |  News | 0 Comment | 06 Dec, 2018

AUM Biosciences (AUM), a Singapore headquartered oncology-focused biotechnology company, has licensed its first novel, highly selective anti-cancer drug, ETC-206, from A*STAR’s Experi...Read more

Chugai's Hemlibra approved in Taiwan

Pharma |  News | 0 Comment | 05 Dec, 2018

Chugai Pharmaceuticals announced that  Chugai Pharma Taiwan, a wholly owned subsidiary of Chugai, obtained approval from the Taiwan Food and Drug Administration (TFDA) for Chugai&rsquo...Read more

Innovent gets USFDA Clinical Trial nod for Anti-OX40 Monoclonal Ab

Pharma |  News | 0 Comment | 05 Dec, 2018

Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announced today that its IND application f...Read more

AGC enters agreement to acquire Malgrat Pharma

Pharma |  News | 0 Comment | 05 Dec, 2018

AGC Inc., a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered into an agreement with Boehringer Ingelheim to acquire Malgrat Pharma C...Read more

Domain Therapeutics collaborates with Boehringer Ingelheim

Pharma |  News | 0 Comment | 05 Dec, 2018

Pharma company, Domain Therapeutics has announced a multi-targetdrug discovery collaboration and licensing agreement with Boehringer Ingelheim on orphan G Protein-Coupled Receptors (GPCRs) ...Read more

Changzhou Qianhong sets up pharma production facility

Pharma |  News | 0 Comment | 05 Dec, 2018

Changzhou Qianhong Bio-pharma Co., Ltd. started construction of the phase two of pharmaceuticals production facility at Changzhou National Hi-Tech District on November 28. With an investmen...Read more